Gynaecological Cancer
8
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Health Seeking Behaviour in Women Diagnosed With Gynaecological Cancer: Can it be Modified to Improve Patient Outcomes?
In Vivo Dosimetry for Brachytherapy Study
Effects of Symptom Management Education With Mobile Application in Gynecological Cancer Patients Receiving Chemotherapy
Palliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE)
Spa Therapy for Upper or Lower Limb Lymphoedema
Side Effects Screening and Early Intervention to Impact in Quality of Life of Gynaecological Cancer Patients
Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center
Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma